Endometriosis in the early second quarter of the 21st century: paradigm shift
Clinical review for general practice · 30.06.2026 · 7 (5) · 100-103
DOI: 10.47407/kr2026.7.5.00848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical review for general practice, online erschienen am 30.06.2026. Verfasst von Mekan R Orazov und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Endometriosis remains a mysterious steadily progressing disease for reproductive medicine of the 21st century. About 10% of women (190 million) of childbearing age all over the world suffer from the disorder. Despite high prevalence, endometriosis is still diagnosed late. The time from first symptoms to the diagnosis varies between 5 and 12 years, depending on the geographic region. This is due to heterogeneity of symptoms and stigma of the issues related to menstrual health, as well as the lack of awareness about the disorder in both medical professionals and patients. In this regard, the review considers endometriosis retrospectively and notes the advances and paradigm shift in the early second quarter of the 21st century. Keywords: endometriosis, epidemiology, comorbidity, risk factors, diagnosis, dienogest, gonadotropin-releasing hormone antagonists, Relugolix.
Zitieren
APA
Orazov, M. R., & Dolgov, E. D. (2026). Endometriosis in the early second quarter of the 21st century: paradigm shift. Clinical review for general practice, 7(5), 100-103. https://doi.org/10.47407/kr2026.7.5.00848
Vancouver
Orazov MR, Dolgov ED. Endometriosis in the early second quarter of the 21st century: paradigm shift. Clinical review for general practice. 2026;7(5):100-103. doi:10.47407/kr2026.7.5.00848
BibTeX
@article{Orazov2026,
author = {Orazov, Mekan R and Dolgov, Evgeny D},
title = {Endometriosis in the early second quarter of the 21st century: paradigm shift},
journal = {Clinical review for general practice},
year = {2026},
volume = {7},
number = {5},
pages = {100--103},
doi = {10.47407/kr2026.7.5.00848}
}
EUVIMED